Skip to main content
Clinical Trials/NL-OMON34952
NL-OMON34952
Recruiting
N/A

Contrast-enhanced harmonic endoscopic ultrasound for pancreatic mass lesions - Contrast EUS

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pancreas mass
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
75
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Adult patient 18 years or older.
  • 2\) Able to read \& write in Dutch.
  • 3\) Undergoing EUS for the evaluation of a solid pancreatic lesion.

Exclusion Criteria

  • 1\) Cystic pancreatic lesion.
  • 2\) Known allergy to Sonovue (contrast agent).
  • 3\) Unstable ischemic heart disease (contra\-indication to Sonovue).

Outcomes

Primary Outcomes

Not specified

Similar Trials